Geoff Twist, managing director of Roche Diagnostics UK and Ireland, analyses the changing mindset he sees at various levels, leaning towards greater recognition of pathology’s impact on health systems. He further highlights some exciting paths Roche Diagnostics is embarking on, such as digital pathology and widened molecular screening programmes.
After a very international career, you have been heading Roche Diagnostics since October 2017. Coming back to your home market, what changes did you observe?
"At Roche Diagnostics, we have a product development process, and this process always starts with customer engagement. Our motto is to incorporate customer insights into our product development thinking."
